Evaluation of short-term and mid-term results of using a cardiopulmonary pump in coronary artery bypass graft surgery

Comparison of Short- and Mid-term Outcomes of Off-pump and On-pump Coronary Artery Bypass Grafting (CABG) surgery in Patients With 3-vessel Coronary Artery Disease: A Randomized Clinical Trial

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190120042428N1

Enrollment

272

Registered

2022-09-16

Start date

2020-06-20

Completion date

Unknown

Last updated

2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary artery disease. Atherosclerotic heart disease of native coronary artery

Interventions

Intervention 1: Intervention group: patients who underwent coronary artery bypass surgery without the use of a cardiopulmonary pump device. In these patients, the anastomosis of the graft vessels on t

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: patients with 3 vessels coronary artery disease Candidates for coronary artery bypass graft surgery

Exclusion criteria

Exclusion criteria: require emergency operation combined valve surgery history of cardiac surgeries patients with cardiogenic shock patients with preoperative Intra-aortic balloon pump patients with single or two vessel disease patients with contraindication to off-pump CABG history of renal failure

Design outcomes

Primary

Measure	Time frame
Major adverse cardiovascular events (MACE). Timepoint: 1, 3, 6, 12 months after surgery and then every 6 months until the end of the study. Method of measurement: The occurrence and type of major adverse cardiovascular events will be recorded during routine visits after surgery (at 1, 3, 6, and 12 month intervals) and at other intervals by telephone follow-up.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSeyed Khalil Forouzannia

Tehran University of Medical Sciences

mmd.forouzan@gmail.com+98 21 8802 9600

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 11, 2026